Erasca, Inc. (ERAS) vs Mirum Pharmaceuticals, Inc. (MIRM)
- Erasca, Inc. ERAS 13.39 −9.95%
- Mirum Pharmaceuticals, Inc. MIRM 80.18 −2.68%
Erasca, Inc. and Mirum Pharmaceuticals, Inc. are both Biotechnology companies. Erasca, Inc. and Mirum Pharmaceuticals, Inc. are of similar size ($5.4B and $5.2B). Erasca, Inc. has the higher net margin (0.00% vs −139.2%) and the lower return on invested capital (−203.1% vs −173.0%). Across the 13 metrics below, Erasca, Inc. leads on 7 and Mirum Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | ERAS | MIRM | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 81.72% | 65.16% |
| Operating margin | 0.00% | (134.93%) | 0.00% |
| Net margin | 0.00% | (139.18%) | 0.00% |
| Free cash flow margin | 0.00% | (44.29%) | 0.00% |
| Return on equity | (78.25%) | (702.97%) | (56.36%) |
| Return on assets | (65.25%) | (97.15%) | (48.04%) |
| Return on invested capital | (203.13%) | (172.96%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack